We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.79B
AUM Growth
+$734M
Cap. Flow
+$336M
Cap. Flow %
5.8%
Top 10 Hldgs %
38.36%
Holding
177
New
61
Increased
32
Reduced
27
Closed
51

Top Buys

Rank Stock Value
1
ALL icon
Allstate
ALL
+$153M
2
WIX icon
WIX.com
WIX
+$144M
3
NFLX icon
Netflix
NFLX
+$115M
4
EXC icon
Exelon
EXC
+$114M
5
PANW icon
Palo Alto Networks
PANW
+$87.9M

Sector Composition

Rank Sector Weight
1 Technology 37.19%
2 Consumer Discretionary 8.42%
3 Healthcare 7.45%
4 Communication Services 6.92%
5 Financials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDU icon
101
CALL
New Oriental
EDU
$9.18B
$4.09M 0.07%
+50,000
New +$6.07M
SGEN
102
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
$3.95M 0.07%
+25,000
New +$3.71M
PARA
103
DELISTED
Paramount Global Class B
PARA
$3.48M 0.06%
77,000
+35,000
+83% +$1.45M
AMWL icon
104
American Well
AMWL
$185M
$3.15M 0.05%
+12,500
New +$3.6M
GNRC icon
105
Generac Holdings
GNRC
$11.4B
$3.03M 0.05%
+7,308
New +$2.45M
DIS icon
106
Walt Disney
DIS
$172B
$2.64M 0.05%
+15,000
New +$2.7M
WBA
107
PUT
DELISTED
Walgreens Boots Alliance
WBA
$2.63M 0.05%
50,000
-75,000
-60% -$4.03M
MRNA icon
108
Moderna
MRNA
$21.6B
$2.35M 0.04%
+10,000
New +$1.79M
BNTX icon
109
BioNTech
BNTX
$23.4B
$2.24M 0.04%
10,000
-17,700
-64% -$3.34M
SAGE
110
DELISTED
Sage Therapeutics
SAGE
$2.06M 0.04%
+36,200
New +$2.56M
DISCK
111
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$2.03M 0.04%
+70,000
New +$2.17M
RDNT icon
112
RadNet
RDNT
$4.89B
$2.02M 0.03%
+60,000
New +$1.58M
SGRY icon
113
Surgery Partners
SGRY
$2.12B
$2M 0.03%
+30,000
New +$1.63M
AGL icon
114
Agilon Health
AGL
$1.58B
$1.62M 0.03%
+1,600
New +$1.4M
UHS icon
115
Universal Health Services
UHS
$10.2B
$1.46M 0.03%
+10,000
New +$1.51M
NTRA icon
116
Natera
NTRA
$35.8B
$1.14M 0.02%
+10,000
New +$1.02M
LGF.A
117
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$1.09M 0.02%
52,500
AAQC.U
118
DELISTED
Accelerate Acquisition Corp Units
AAQC.U
$1.01M 0.02%
+100,000
New +$1M
BHIL
119
DELISTED
Benson Hill, Inc.
BHIL
$990K 0.02%
+2,857
New +$1M
ALT icon
120
Altimmune
ALT
$578M
$985K 0.02%
+100,000
New +$1.37M
BOAC
121
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
$981K 0.02%
+100,000
New +$990K
JWSM
122
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$976K 0.02%
+100,000
New +$986K
AGCB
123
DELISTED
Altimeter Growth Corp 2
AGCB
$279K ﹤0.01%
27,187
NOVA
124
DELISTED
Sunnova Energy
NOVA
$213K ﹤0.01%
5,646
-1,760
-24% -$58.5K
OTLKW
125
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$32K ﹤0.01%
100,000

Similar funds

PointState Capital's Q2 2021 Portfolio in Review

As of Q2 2021, PointState Capital held 177 positions worth $5.79B, up 15% from $5.06B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PointState Capital deployed $336M of net new capital in Q2 2021, opening 61 new positions and adding to 32 existing holdings. Its largest new stake was Allstate: 1,184,898 shares worth $155M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $127M trimmed.

  • PointState Capital's largest Q2 2021 buy was Allstate: 1,184,898 shares worth $155M.
  • PointState Capital added most to Netflix in Q2 2021, an estimated $115M increase.
  • PointState Capital's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $127M.
  • PointState Capital fully exited Alphabet (Google) Class A in Q2 2021, selling an estimated $152M.
  • PointState Capital's ten largest holdings make up 38% of its $5.79B portfolio in Q2 2021.
  • PointState Capital opened 61 new positions and closed 51 in Q2 2021.
  • PointState Capital's portfolio value rose 15% quarter-over-quarter to $5.79B.

Based on PointState Capital's 13F filing for Q2 2021, filed 13 Aug 2021.